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Abstract
Background:  The development of protocols for RNA extraction from paraffin-embedded
samples facilitates gene expression studies on archival samples with known clinical outcome. Older
samples are particularly valuable because they are associated with longer clinical follow up. RNA
extracted from formalin-fixed paraffin-embedded (FFPE) tissue is problematic due to chemical
modifications and continued degradation over time. We compared quantity and quality of RNA
extracted by four different protocols from 14 ten year old and 14 recently archived (three to ten
months old) FFPE breast cancer tissues. Using three spin column purification-based protocols and
one magnetic bead-based protocol, total RNA was extracted in triplicate, generating 336 RNA
extraction experiments. RNA fragment size was assayed by reverse transcription-polymerase chain
reaction (RT-PCR) for the housekeeping gene glucose-6-phosphate dehydrogenase (G6PD), testing
primer sets designed to target RNA fragment sizes of 67 bp, 151 bp, and 242 bp.
Results: Biologically useful RNA (minimum RNA integrity number, RIN, 1.4) was extracted in at
least one of three attempts of each protocol in 86–100% of older and 100% of recently archived
("months old") samples. Short RNA fragments up to 151 bp were assayable by RT-PCR for G6PD
in all ten year old and months old tissues tested, but none of the ten year old and only 43% of
months old samples showed amplification if the targeted fragment was 242 bp.
Conclusion: All protocols extracted RNA from ten year old FFPE samples with a minimum RIN
of 1.4. Gene expression of G6PD could be measured in all samples, old and recent, using RT-PCR
primers designed for RNA fragments up to 151 bp. RNA quality from ten year old FFPE samples
was similar to that extracted from months old samples, but quantity and success rate were
generally higher for the months old group. We preferred the magnetic bead-based protocol
because of its speed and higher quantity of extracted RNA, although it produced similar quality
RNA to other protocols. If a chosen protocol fails to extract biologically useful RNA from a given
sample in a first attempt, another attempt and then another protocol should be tried before
excluding the case from molecular analysis.
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Background
For decades, human tissue samples obtained from surgical
procedures have been routinely fixed in formalin and
embedded in paraffin for long-term storage. Conse-
quently, most institutions have large paraffin-block
archives that allow long-term follow up for all types of
neoplasms, including rare tumors. These archives repre-
sent a valuable source for molecular studies. A major lim-
itation for the use of such samples to study gene
expression is three-fold: RNA can degrade prior to forma-
lin fixation; formalin fixation produces significant chemi-
cal modification of RNA; and RNA continues to fragment
and degrade over time, even after dehydration and paraf-
fin-embedding.
Immediate freezing of fresh tissue samples preserves good
quality RNA for gene expression studies; however, this
procedure is not routinely performed in most hospitals
and there are few institutions worldwide that have large
frozen-tissue banks associated with long term clinical fol-
lowup. Moreover, tumor samples accrued into a frozen
tissue bank are inherently biased in their collection: such
tumors must be sufficiently large and palpable in order for
tissue to be excised and frozen for the bank [1].
Formalin-fixed paraffin-embedded (FFPE) samples are
universally available and, with Institutional Review
Board/Ethics Committee approval, cancer samples can be
linked to clinical and/or follow up information, often
available through an institution's tumor registry. Extract-
ing RNA from such samples has been a promising but
problematic challenge. In addition to RNA degradation
concerns, formalin fixation creates cross-linking between
nucleic acids and proteins and adds mono-methylol to
amino groups for all four RNA bases (N-CH2OH); meth-
ylene bridging then occurs between neighboring bases (N-
CH2-N), formed by condensation of amino bases and N-
methylols [2].
Rupp and Locker described the first successful RNA extrac-
tion from FFPE samples in 1988 [3]. Since then, many
protocols have been described [2,4-11]. There are cur-
rently multiple protocols commercially available. In most
of these protocols the RNA is extracted by spin column
purification according to similar basic principles: depar-
affinization, followed by cell disruption with heated pro-
teinase K, which is capable of efficiently degrading
proteins that were covalently cross-linked with each other
and RNA, thereby allowing more efficient RNA extraction
than achieved by use of chaotropic agents such as gua-
nidinium chloride [7]. Proteinase K incubation at high
temperature (60 to 70°C) also removes part of the meth-
ylol additions induced by formalin fixation [7]. After pro-
teinase K incubation, RNA is isolated by alcohol
precipitation and though use of salt guanidine thiocy-
anate in a spin column purification step [2,12].
Magnetic beads can also be utilized to isolate RNA. In
these protocols, nucleic acids are bonded to paramagnetic
beads and isolated by a magnetic field. RNA is isolated
using an optimized buffer solution and later a DNAse
step. Magnetic micro-beads can be prepared in a number
of ways, but usually magnetically susceptible particles
(e.g. iron oxide) are coated with synthetic or biological
polymers with high affinity for nucleic acid. A magnet is
applied to the side of the tube containing the magneti-
cally-labeled sample mixture and the magnetically bound
nucleic acid aggregates near the wall of the tube, allowing
the unlabeled materials to be pipetted off and discarded.
In addition to quickly separating magnetically-bound
nucleic acid, this method does not create the shear forces
generated by spin centrifugation that may lead to nucleic
acid degradation [13].
Breast cancer tissue RNA archived for one year is less
degraded and has larger average molecular weight than
RNA archived for six and 17 years, suggesting that frag-
mentation of FFPE tissue continues even after specimens
are dehydrated and embedded in paraffin [9]. Many
molecular techniques depend upon the quantity and
quality of extracted RNA in samples; translational studies
that link molecular findings to clinical outcome require
long term follow up. Here we compare RNA extraction
protocols on a set of 14 ten year old FFPE breast cancer
samples, testing spin column purification and magnetic
bead-based technologies. Using the same protocols, we
compare our results with a second set of 14 recently
archived breast cancer samples fixed and embedded in
paraffin three to ten months prior to this study, that we
designate "months old" samples. We also test RNA frag-
ment size in both sample groups using RT-PCR for the
housekeeping gene G6PD.
Results
Table 1 exhibits 168 RNA extraction experiments per-
formed on 14 ten year old archived FFPE breast cancer
samples, showing RNA quantity (in pg/μl) and quality (by
RNA integrity number, RIN) for RNA that was extracted in
triplicate using four different extraction protocols. Simi-
larly, Table 2 shows 168 RNA extraction experiments on
14 FFPE breast cancer samples that are months old,
archived three to ten months prior to analysis, again with
RNA extracted in triplicate using each of the four proto-
cols. Tables 3 and 4 show the minimum and maximum
values, means, and medians for each of the protocols con-
cerning the quantity and the quality of the extracted RNA,
in the ten year old and months old set of samples, respec-
tively. Tables 5 and 6 show the same parameters, but onlyBMC Molecular Biology 2007, 8:118 http://www.biomedcentral.com/1471-2199/8/118
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for samples that had biologically useful RNA extracted,
defined as RNA with a minimum RIN of 1.4.
In the set of ten year old samples (Tables 1 and 5), proto-
cols 1, 2, 3, and 4 extracted RNA with a minimum RIN of
1.4 in, respectively, 26, 26, 35, and 30 of the 42 triplicate
RNA extraction procedures performed for each protocol.
Thus, the success rate for extracting biologically useful
RNA with protocols 1, 2, 3, and 4 was 62%, 62%, 83%,
and 71%, respectively. When analyzed on a per sample
basis, protocols 1–4 produced biologically useful RNA in
at least one of three extractions for, respectively, 12, 14,
13, and 13 out of 14 cases in the set for a case success rate
of, respectively, 86%, 100%, 93%, and 93%.
For the set of recently archived months old samples
(Tables 2 and 6), protocols 1, 2, 3, and 4 extracted RNA
with a minimum RIN of 1.4 in, respectively, 34, 34, 39,
and 35 of the 42 RNA extraction procedures performed for
each protocol, giving a success rate for extracting biologi-
cally useful RNA of 81%, 81%, 93%, and 83%, respec-
tively. The case success rate was 100% for all four
protocols; in other words, each protocol was able to
extract RNA with a RIN ≥ 1.4 in at least one of the three
attempts for every case in this set.
RT-PCR for the housekeeping gene glucose-6-phosphate
dehydrogenase (6GPD) was performed using primers that
targeted different fragment sizes of extracted RNA. All
samples from both one and ten year old sets successfully
amplified 67 bp and 151 bp fragments of G6PD mRNA.
However, when primers targeting 242 bp fragments were
tested, only six of 14 (43%) months old FFPE samples and
none of the ten year old samples demonstrated G6PD
gene expression (Figure 1).
Discussion
Biopsies and surgical specimens are routinely fixed in for-
malin and embedded in paraffin for histological analysis.
Although the morphological integrity of the tissues is pre-
served, this procedure causes degradation of nucleic acids,
predominantly RNA. The development of protocols for
RNA extraction from these samples makes it possible to
molecularly study long-term archived tissues, opening
new perspectives for research and diagnostic investiga-
tion. Soguero et al. were able to extract RNA in more than
Table 1: Comparison of the four RNA extraction protocols in ten year old samples, by quantity of extracted RNA (in pg/μl) and RNA 
quality (by RNA integrity number, RIN). NM = not measurable.
Sample Parameter Protocol 1 Protocol 2 Protocol 3 Protocol 4
Test 1 Test 2 Test 3 Test 1 Test 2 Test 3 Test 1 Test 2 Test 3 Test 1 Test 2 Test 3
1 RNA 91,464 73,861 29,225 32,507 110,621 47,418 21,078 53,731 77,500 231,085 301,416 258,839
RIN NM 2.3 2.0 3.5 3.2 NM 2.2 NM 2.1 NM 2 NM
2 RNA 27,124 4,836 17,711 165,588 63,934 159,656 38,415 43,935 17,635 144,770 110,373 187,249
RIN 1.7 1.1 2.0 2.1 NM 2.1 2.2 2.4 1.9 2.0 2.3 2.2
3 RNA 1,236 1,278 6,012 11,050 5,570 7,671 1,416 1,314 18,106 30,239 40,763 105,048
RIN 2.3 1.0 2.2 2.3 NM 2.3 2.4 2.5 2.6 1.8 2.2 5.5
4 RNA 5,103 31,145 18,353 71,598 25,791 18,397 34,381 20,229 8,557 122,541 90,564 86,324
RIN NM 2.3 NM 2.2 2.9 NM 2.3 2.2 2.1 NM NM NM
5 RNA 5,146 2,893 7,262 43,901 5,140 8,624 29,711 14,415 11,391 68,768 72,550 76,048
RIN 1.7 1.1 2.4 NM 2.3 2.3 NM 2.4 2.3 2.2 2.2 6.1
6 RNA 11,416 4,282 975 99,045 27,804 30,150 18,686 14,128 31,289 23,427 84,711 98,565
RIN NM 1.0 1.0 2.2 2.7 NM 2.4 2.4 2.1 NM 2.2 NM
7 RNA 160,254 6,878 7,584 98,598 56,896 39,390 16,501 48,935 6,070 62,394 196,847 150,394
RIN NM 1.0 1.1 2.2 2.5 2.2 1.2 1.0 1.1 2.6 2.2 2.2
8 RNA 65,752 2,088 9,915 66,706 28,998 18,004 46,519 12,300 31,952 12,900 87,934 85,429
RIN 1.2 1.8 2.1 3.2 NM NM 2.4 2.4 2.2 NM 2.2 1.9
9 RNA 15,123 15,579 20,517 32,962 21,034 265,694 137,594 65,451 46,768 101,909 132,994 95,334
RIN 1.5 1.1 2.2 5.2 NM NM 2.2 2.1 2.1 NM 2.3 2.1
10 RNA 31,042 36,583 12,392 68,465 26,950 25,458 35,551 74,122 11,543 35,885 76,333 42,892
RIN 2.2 2.3 2.1 NM 2.3 2.3 3.6 4.4 2.2 NM 2.3 1.9
11 RNA 19,588 14,991 11,954 30,333 26,505 18,184 34,319 39,265 12,859 39,093 56,516 17,502
RIN 2.2 1.4 2.1 NM 2.3 2.4 2.5 NM 1.9 2.2 2.2 2.1
12 RNA 5,883 3,042 10,918 29,701 106,627 35,362 67,125 28,579 12,037 188,026 314,693 91,516
RIN 2 1 NM 1.5 2.1 NM 2.3 2.4 2.3 2.1 2.1 2.1
13 RNA 30,578 36,224 3,943 45,229 74,659 5,371 21,065 11,367 6,659 111,666 190,653 33,443
RIN 2.2 2.3 1.8 NM 2.1 NM 2.2 2.3 2.1 2.1 2 NM
14 RNA 3,099 4,057 4,915 22,218 1,650 12,581 9,518 4,916 17,807 9,864 7,790 39,253
RIN 2.3 2.5 1.9 2.4 2.3 NM 2.2 NM 2.3 2.3 NM 2.1BMC Molecular Biology 2007, 8:118 http://www.biomedcentral.com/1471-2199/8/118
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20 year-old archival liver tissue [14]. In breast cancer,
long-term follow-up is important because the time to
developing distant metastases and death can vary greatly,
with both recurrence time and death extending beyond 15
years after surgery [15-17]. Even patients with small
tumors (stage T1N0M0) may have 10-year relapse-free
survival rates of less than 75% in the absence of systemic
therapy [18].
In addition to the impact of long-term storage, RNA can
also be degraded during the relative delay associated with
putting the specimen in fixative following surgical exci-
sion and by prolonged fixation prior to paraffin embed-
ding [19]. However, the greater challenge is that RNA is
chemically modified during formalin-fixation. Fortu-
nately, some of the alterations can be reversed by heating
the RNA to 50–55°C [2]. Many attempts have been made
Table 2: Comparison of the four RNA extraction protocols in recently archived months old samples, by quantity of extracted RNA (in 
pg/μl) and RNA quality (RNA integrity number, RIN). NM = not measurable.
Sample Parameter Protocol 1 Protocol 2 Protocol 3 Protocol 4
Test 1 Test 2 Test 3 Test 1 Test 2 Test 3 Test 1 Test 2 Test 3 Test 1 Test 2 Test 3
15 RNA 26,717 75,411 4,886 13 56,455 105,945 21,028 4,606 115,194 184,832 44,758 176,904
RIN 2.5 2.3 2.3 NM 2.3 1.7 2.3 2.3 2 2 2.4 NM
16 RNA 33,327 935 2,392 16,843 108,984 42,670 39,120 4,989 38,314 283 195,149 3,590
RIN NM 1.5 2.0 1.8 2.0 2.0 2.3 1.1 2.4 NM 2.1 2.6
17 RNA 12,321 15,143 24,286 16,752 94,246 16,075 4,211 73,366 59,072 25,535 102,053 48,459
RIN 2.4 2.3 2.1 1.9 2.0 2.1 2.4 1 2.2 NM 2.0 1.9
18 RNA 151,098 2,987 54,397 45,924 201,780 34,506 57,940 9,608 92,135 34 1,430 709
RIN NM 2.5 1.1 2.3 1.9 2.6 2.2 2.3 2.6 1.4 2.4 1.5
19 RNA 574 5,060 8,632 44,190 6,633 9,835 7,852 15,146 12,487 5,893 177,677 38,735
RIN 2.6 2.4 2.3 1.6 NM 2.4 2.5 2.4 2.4 2.3 2.2 2.3
20 RNA 32,152 25,444 43,271 5,011 1,943 129,140 12,681 48,499 41,880 9,862 680,783 51,245
RIN 2.1 2.2 1.9 NM 2.1 1.9 2.1 2.1 2.3 NM 2.0 2.0
21 RNA 129 33,579 53,338 5,586 15,692 112,909 5,494 15,487 24,668 88,118 2,209,739 19,185
RIN NM 2.5 2.3 NM 2.5 2.3 2.4 2.5 2.4 2.3 2.1 2.5
22 RNA 10,368 28,093 8,781 20,750 47,818 337,413 10,810 21,020 13,080 86,567 1,989,467 45,987
RIN 2.3 2.3 1.5 2.0 2.7 NM 2.2 2.4 2.4 2.2 NM 2.0
23 RNA 506 14,419 9,737 10,198 48,692 448,764 2,406 11,445 14,051 96,318 183 3,569
RIN NM 2.3 1.6 2.0 2.0 NM 1.4 2.3 2.3 2.0 NM 2.3
24 RNA 79,734 42,491 70,454 94,699 98,831 122,026 4,048 104,887 18,737 23,212 437,911 35,536
RIN NM 2.5 2.2 1.9 NM 2 2.2 2.4 2.4 2.8 1.9 2.3
25 RNA 434 7,322 23,764 55,950 51,147 23,779 11,479 3,797 987 51,691 12,175 57,595
RIN 1.7 2.4 2.2 2.0 1.9 2.5 2.5 2.5 2.4 1.8 NM 2.1
26 RNA 7,197 22,423 26,426 36,685 46,714 73,221 22,950 3,085 672 52,705 343,366 118,509
RIN 2.5 2.5 NM 2.2 NM 2.3 2.5 2.4 1.1 2.1 2.3 2.2
27 RNA 398 76 6,558 47,083 59,324 126,065 76,154 5,985 22,133 28,011 137 934
RIN 2.6 5.1 1.2 2.0 1.9 2.4 2.4 2.4 2.4 2.5 3.1 4.9
28 RNA 25,430 19,610 185,70
3
152 56,276 259,012 11,032 38,413 24,973 66,103 1,307,318 150,052
RIN 2.4 2.5 2.4 2.1 2.3 2.2 2.4 2.3 2.4 2.5 2.1 2.0
Table 3: Overall comparison of the four RNA extraction protocols for quantity (in pg/μl) and quality (RIN) for ten year old FFPE 
samples.
Ten year old samples: Protocol 1 Protocol 2 Protocol 3 Protocol 4
FFPE tissue input 80 μm1 0   μm2 0   μm5 0   μm
Successful extractions 36/42 (86%) 26/42 (62%) 38/42 (90%) 30/42 (71%)
RNA (pg/μl) Minimum value 975 1,650 1,314 9864
Maximum value 73,861 165,588 137,594 314,693
Mean 15,964 51,985 29,661 107,042
Median 8,750 31,104 19,458 86,682
RIN Minimum value 1.0 1.5 1.0 1.8
Maximum value 2.5 5.2 4.4 6.1
Mean 1.8 2.5 2.3 2.4
Median 2.0 2.3 2.2 2.2BMC Molecular Biology 2007, 8:118 http://www.biomedcentral.com/1471-2199/8/118
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to avoid these chemical modifications by proposing use of
alternative fixatives such as Bouin, Carnoy, acetone, and
alcohol as substitutes for formalin [5,10,20]. These fixa-
tives, however, introduce tissue artifacts that can make
microscopic histopathological analysis difficult or even
impossible. Moreover, these fixatives are not suitable for
immunohistochemistry reactions, much more common
in pathologic practice than gene expression analyses.
Finally, samples in most archives are already fixed in for-
malin. So, for retrospective studies, it is imperative to
develop and/or refine protocols for RNA extraction from
FFPE.
The first step in RNA extraction from FFPE samples is
deparaffinization of the sections obtained from the paraf-
fin blocks. When deparaffinization is incomplete, the
extracted RNA quality is worse [21]. In our work, in the set
of 10-year-old samples, both the quantity and quality of
RNA extracted with the deparaffinization solution d-
limonene (protocols 2 and 3) were higher than that
obtained using xylene – also known as xylol, dimethyl-
benzene, or methyltoluene – (protocol 1) (Tables 3 and
5). Due to other protocol differences, we cannot assess the
impact of the deparaffinizing agent alone. It is worthy to
note, however, that with the set of recently archived
months old samples, the differences between protocols is
smaller (Tables 4 and 6).
Historically, RNA integrity has been evaluated using agar-
ose gel electrophoresis stained with ethidium bromide.
Typically these gels show two peaks that correspond to
ribosomal RNA species 28S and 18S. According to this
technique, a given RNA sample is considered of good
quality when the relation 28S:18S is equal to or higher
than 2 [22]. The 2100 Bioanalyzer (Agilent Technologies,
Santa Clara, CA) is a microfluidic platform that uses elec-
trophoretic separation of RNA by molecular weight and
provides laser-induced fluorescence measurements. Using
electropherogram curves, 1208 RNA samples from differ-
ent sources and in different degrees of degradation were
analyzed and an algorithm was created to determine RNA
integrity number (RIN). The RIN for a given sample
ranges from 1 to 10, from totally degraded RNA to com-
pletely intact RNA [22]. The RIN method is superior to the
28S/18S ratio method for evaluating RNA quality in
breast cancer tissue [23].
Table 5: Comparison of the four protocols for quantity and quality of extracted RNA for only samples that produced biologically-useful 
RNA (RIN ≥ 1.4) in ten year old FFPE samples. Case success is defined for each protocol as the percentage of samples where at least 
one of three RNA extraction attempts provided a RIN ≥ 1.4.
Ten year old samples: Protocol 1 Protocol 2 Protocol 3 Protocol 4
FFPE tissue input 80 μm1 0   μm2 0   μm5 0   μm
Successful extractions 26/42 (62%) 26/42 (62%) 35/42 (83%) 30/42 (71%)
Case success 12/14 (86%) 14/14 (100%) 13/14 (93%) 13/14 (93%)
RNA (pg/μl) Minimum value 1,236 1,650 1,314 9,864
Maximum value 73,861 165,588 137,594 314,693
Mean 17,754 51,985 30,160 107,042
Median 13,692 31,104 20,229 86,682
Minimum RIN of 1.4 Minimum value 1.4 1.5 1.9 1.8
Maximum value 2.5 5.2 4.4 6.1
Mean 2.0 2.5 2.3 2.4
Median 2.1 2.3 2.3 2.2
Table 4: Overall comparison of the four RNA extraction protocols for quantity (in pg/μl) and quality (RIN) for recently archived 
months old FFPE samples.
Months old samples: Protocol 1 Protocol 2 Protocol 3 Protocol 4
FFPE tissue input 80 μm1 0   μm2 0   μm5 0   μm
Successful extractions 36/42 (86%) 34/42 (81%) 42/42 (100%) 35/42 (83 %)
RNA (pg/μl) Minimum value 76 152 672 34
Maximum value 185,703 259,012 115,194 2,209,739
Mean 25,133 64,317 26,808 180,584
Median 14,782 48,255 14,599 51,245
RIN Minimum value 1.1 1.6 1.0 1.4
Maximum value 5.1 2.7 2.6 4.9
Mean 2.2 2.1 2.2 2.3
Median 2.3 2.0 2.4 2.2BMC Molecular Biology 2007, 8:118 http://www.biomedcentral.com/1471-2199/8/118
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In frozen tissues, a RIN ≥ 6 provides more reproducible
microarray results [23]. In FFPE samples, however, the
RIN is much lower because RNA continues to degrade
over time into small fragments. However, even low RIN
RNA may still be used for some molecular analyses. Frag-
ments of only 60 bp have been shown to successfully
amplify in 80% of real-time RT-PCR reactions; even with
FFPE samples stored long-term [24]. RNA extracted from
2- to 8-year-old FFPE produces RNA of sufficient quality
for microarray analysis in at least 24% of unselected FFPE
samples [25].
In frozen breast cancer tissue Strand et al. suggested a min-
imum RIN of 6 for gene expression analysis [23]. How-
ever, according to Madabusi et al., RNA with a RIN as low
as 1.4 have been successfully used for gene expression
analysis [12]. In our set of ten year old samples, using a
minimum RIN of 1.4 as a threshold for RNA quality, only
protocol 2 extracted RNA with a minimally acceptable
quality for all 14 samples analyzed, 100% (Table 1). Pro-
tocol 1 extracted minimally acceptable RNA in 12 of 14
cases, 86% (failing to isolate minimally acceptable RNA
for samples 6 and 7, even with three attempts). Protocol 3
extracted minimally acceptable RNA in 13 of 14 cases,
93% (failing for sample 7, even with three attempts). Pro-
tocol 4 extracted minimally acceptable RNA in 13 of 14
cases, 93% (failing for sample 4, even with three attempts)
(Table 1). In the set of recently archived months old sam-
ples (Table 2), however, it was possible to extract RNA
with a minimally acceptable quality in all 14 samples ana-
lyzed with all four protocols. These data indicate that ten
year old RNA, and specifically RNA that is biologically
assayable, could be isolated from every sample by at least
one and usually most of the protocols. These data indicate
that, if a chosen protocol fails to extract RNA from a given
case in a first attempt, another attempt should be tried.
However, in our series, if two initial attempts were unsuc-
cessful, a third attempt using the same protocol was less
likely to yield biologically usable results, especially for
older samples. Thus, we recommend switching RNA isola-
tion protocols after a second failed attempt. It would be
unusual to completely exclude a case from molecular
analysis because of insufficient or poor quality RNA.
Another important observation can be made in a careful
analysis of Tables 1 and 2. There are discrepancies in both
quantity and quality of extracted RNA among individual
cases for each of the protocols. For example, in sample 7,
with protocol 1, test 1, it was possible to extract 160,254
pg/μl of RNA. The quality of this RNA, however, showed
Amplification of G6PD by multiplex RT-PCR and analyzed by  electrophoresis on 2% agarose gels Figure 1
Amplification of G6PD by multiplex RT-PCR and analyzed by elec-
trophoresis on 2% agarose gels. A. Representative examples of 
amplification products from RNA extracted from ten year old 
FFPE, samples 6 and 12; B. representative examples of amplifica-
tion products from RNA extracted from recently archived 
months old FFPE, samples 15, 23, 22, 24. RNA fragments 
extracted from all 28 of the ten year old and months old samples 
were of sufficient size to generate shorter amplicons of G6PD 67 
bp and 151 bp, visible on the gel; the 242 bp amplicon was visual-
ized in none of the 10 year old samples and only six of 14 (43%) of 
the months old samples. All non-visualizing amplification products 
in the multiplex experiments were confirmed by PCR with single 
primer sets. M = marker (DNA ladder).
A.
650
500
400
300
200
100
6 12 M  15 Sample 23 22 24 M bp
B.
Table 6: Comparison of the four protocols for quantity and quality of extracted RNA for only samples that produced biologically-useful 
RNA (RIN ≥ 1.4) in recently archived months old FFPE samples. Case success is defined for each protocol as the percentage of samples 
where at least one of three RNA extraction attempts provided a RIN ≥ 1.4.
Months old samples: Protocol 1 Protocol 2 Protocol 3 Protocol 4
FFPE tissue input 80 μm1 0   μm2 0   μm5 0   μm
Successful extractions 34/42 (81%) 34/42 (81%) 39/42 (93%) 35/42 (83%)
Case success 14/14 (100%) 14/14 (100%) 14/14 (100%) 14/14 (100%)
RNA (pg/μl) Minimum value 76 152 987 34
Maximum value 185,703 259,012 115,194 2,209,739
Mean 24,818 64,317 26,843 180,584
Median 14,781 48,255 15,146 51,245
Minimum RIN of 1.4 Minimum value 1.5 1.6 1.4 1.4
Maximum value 5.1 2.7 2.6 4.9
Mean 2.3 2.1 2.3 2.3
Median 2.3 2.0 2.4 2.2BMC Molecular Biology 2007, 8:118 http://www.biomedcentral.com/1471-2199/8/118
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complete degradation, without a measurable RIN. On the
other hand, in sample 3, with protocol 1, test 1, only
1,236 pg/μl was extracted, but the RIN was 2.3. These data
corroborate the observation made by Chung et al. that
quantity and quality are independent parameters in RNA
extraction [21].
For all parameters analyzed, both for quantity and qual-
ity, Protocol 1 did not perform as well as other protocols
on our ten year old archived breast tissue, although it still
produced sufficient RNA from most samples (Tables 1
and 3). Of the remaining three protocols (Table 3), proto-
col 2 extracted slightly higher quality RNA (RIN mean/
median: 2.5/2.3) than protocols 3 and 4 (RIN mean/
median: 2.3/2.2 and 2.4/2.2, respectively). However, pro-
tocol 4 extracted more RNA than the other protocols
(mean of 107,042 pg/μl and median 86,682 pg/μl)
(Tables 1 and 3). Protocol 4 used a total of 50 μm of tissue
sections compared to 10 μm and 20 μm tissue sections
used in protocols 2 and 3; it might be argued, therefore,
that the reason protocol 4 extracted more RNA than pro-
tocols 2 and 3 was higher input of tumor tissue. However,
protocol 1 had the highest input of tissue, 80 μm, yet
extracted less RNA than the other protocols. Thus, the
quantity of extracted RNA may or may not be related to
tissue input. Protocol 2, which used only 10 μm of tissue
input, may be a good choice when the amount of availa-
ble tissue is scarce.
When we compared the results of the ten year old and
recently archived months old samples in the extraction of
biologically useful RNA (Tables 5 and 6), there were no
significant differences in quality of extracted RNA
between these different aged sample groups. The months
old samples showed somewhat higher mean and median
quantities of extracted RNA, except for Protocol 3, which
extracted slightly higher amounts of RNA from the older
tissues. All protocols, without exception, extracted biolog-
ically useful RNA in a higher percentage of attempts for
months old compared to ten year old samples, although
biologically useful RNA was still successfully extracted
from each of the older samples a high percentage of the
time.
Our RT-PCR data indicated that biologically useful RNA
extracted from archivally stored FFPE tissue is suitable for
RT-PCR analysis if the final product of amplification is
designed to be 151 bp or less. We had a success rate of
100% for both the ten year old and more recently archived
months old samples using primers for the housekeeping
gene G6PD that amplified 67 bp and 151 bp. Successful
amplification was achieved in none of our ten year old
samples and in only 43% of our recently archived months
old samples if the amplified fragment was 242 bp. This
result is consistent with expected RNA degradation over
time. However, the lower quantity of extracted RNA from
ten year old samples that was used for the RT-PCR may
also have contributed to the result. Liu et al.[26], who
cleverly designed the primers also used in this study,
reported successful RT-PCR of 91% and 76% for 67 bp
and 151 bp fragments of G6PD mRNA, respectively, but
only 5% for 242 bp fragments measured from archival
histologic specimens of diverse tissues (including decalci-
fied specimen from bone) between one and 15 years old.
RT-PCR of genes other than G6PD or use of RNA extracted
from FFPE from other tissue sources could potentially
produce different results.
All four protocols were time-consuming (one working-
day for protocols 1, 3, and 4; two days for protocol 2
because of an overnight Proteinase K digestion), but easy
to use. We personally appreciated the speed and quantity
of RNA extracted using Protocol 4.
Conclusion
In conclusion, although the magnetic bead-based proto-
col extracted more RNA than spin column-based proto-
cols, all protocols were able to extract RNA with a
minimally acceptable quality from ten year old archived
FFPE samples. Although the quality of RNA extracted
from ten year old FFPE was similar to the RNA extracted
from recently archived months old samples, the quantity,
consistency and success rate was higher in the months old
group. The RNA extracted from FFPE is suitable for RT-
PCR analysis if the final product of amplification is up to
151 bp, with a success rate of 100% for both ten year old
one and months old samples. If a chosen protocol fails to
extract RNA from a given case in a first attempt, another
extraction and then an alternative protocol should be
attempted before excluding this case from further molec-
ular analysis.
Methods
Samples
The study conformed to the ethical guidelines of the 1975
Declaration of Helsinki and was approved by the Ribeirão
Preto local Ethics Committee, Brazil, and Stanford Uni-
versity. Twenty-eight paraffin blocks containing breast
cancers diagnosed in 1997 (n = 14 samples, ten years old)
and 2007 (n = 14 samples, three to ten months old) were
retrieved from the archives of the Pathology Service of the
General Hospital of Ribeirão Preto Medical School, Uni-
versity of São Paulo, Brazil. Each block contained one
piece of breast cancer tissue measuring at least 1.5 × 1.5
cm in area. Using a conventional microtome (Leica
RM2125), histological sections 10 microns in thickness
were cut from each block according to protocol specifica-
tions (Table 7). A new sterile blade was used for each
block to avoid contamination among the samples. All
reactions were performed in an RNase-free environment;BMC Molecular Biology 2007, 8:118 http://www.biomedcentral.com/1471-2199/8/118
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benches, instruments, and pipetters were cleaned and
treated with RNaseZap solution (Ambion Inc., Austin, TX)
before each reaction, and RNase-free tips and microtubes
were used.
RNA extraction
All protocols were performed according to Manufacturer's
instructions using their specified input of FFPE tissue sec-
tions (Table 7). Protocol 1 utilized the kit "RecoverAll™
Total Nucleic Acid Isolation Optimized for FFPE Samples"
(Ambion Inc., Austin, TX) [27]. Protocol 2 utilized the
"High Pure RNA Paraffin Kit" (Roche Applied Science,
Indianapolis, IN) [28]. Protocol 3 utilized the "Absolutely
RNA® FFPE Kit" (Stratagene, La Jolla, CA) [29]. Briefly,
these three protocols share six steps: histological section-
ing of FFPE tissue blocks, deparaffinization, Proteinase K
digestion, RNA isolation, DNase incubation and RNA
purification. Table 7 highlights the main differences
among the three column purification-based protocols
used in this work.
Protocol 4 utilized the Agencourt®  "FormaPure™ Kit"
(Agencourt, Beverly, MA) [30] followed by DNAse I diges-
tion (Ambion Inc., Austin, TX). This kit utilizes Solid
Phase Reversible Immobilization (SPRI®) paramagnetic
bead-based technology to isolate RNA from a maximum
input of 10 mg of FFPE tissue (according to manufac-
turer's instructions, we used five 10 μm sections from each
paraffin block). Similar to other protocols, a reagent (lysis
buffer provided by the kit) is added to melt the paraffin
and de-crosslink nucleic acids, and Proteinase K is added
to complete tissue digestion and inactivate nucleases (60
minutes incubation time at 55°C). Contrary to the other
three protocols, binding buffer is added to facilitate
immobilization of the nucleic acids to the surface of par-
amagnetic beads and separation is magnetically-per-
formed. This protocol does not require centrifugation.
The RNA extraction from each of the 28 cases was done in
triplicate: 84 extractions per protocol for each of the four
protocols, for a total of 336 RNA extraction procedures.
Evaluation of quantity and quality of the extracted RNA
The RNA extracted in triplicate from the 28 breast cancer
samples using the four protocols was analyzed (n = 336)
for quantity and quality. To rapidly quantify RNA, the Agi-
lent 2100 Bioanalyzer (Agilent Technologies, Santa Clara,
CA), a chip-based nucleic acid separation system, was
used. The Bioanalyzer utilizes a combination of micro-flu-
idics, capillary electrophoresis, and fluorimetry to deter-
mine RNA length, distribution and concentration [22,23].
The RNA 6000 Pico Kit (Agilent Technologies, Santa
Clara, CA) was used together with a standardized RNA
ladder (Ambion, Austin, TX) for RNA analysis and quan-
tification. The quantity of RNA was expressed in pg/μl
(per the PicoChip) and the quality was expressed by the
RNA integrity number (RIN). For both quantity and RIN,
the following parameters were evaluated: minimum
value, maximum value, mean value, and median value
using the statistical software GraphPad Prism, version 4.0
(San Diego, CA). Only samples which had measurable
RINs were included in the analyses. Case success was
defined for each protocol as the percentage of samples in
the 14 sample set in which at least one of three RNA
extraction attempts provided biologically useful RNA with
a RIN ≥ 1.4.
RT-PCR for assaying RNA fragment size using different 
target lengths for glucose-6-phosphate dehydrogenase 
(G6PD)
To determine fragment sizes of RNA extracted from archi-
val FFPE specimens, we targeted the housekeeping gene
G6PD with different mRNA primer sets and performed
RT-PCR as described by Liu et al.[26]. From each of the 28
FFPE samples included in this study (14 ten year old sam-
ples and 14 months old samples), extracted RNA with
RINs greater than 1.4 were used for RT-PCR analyses.
All primers were designed by Liu et al. One sense primer
(5'-GGC AAC AGA TAC AAG AAC GTG AA) and three
antisense primers were used such that combinations of
these primers would generate PCR amplicons of 67 bp (5'-
CGC AGA AGA CGT CCA GGA T), 151 bp (5'-CCA GCT
CAA TCT GGT GCA G), and 242 bp (5'-CCC TCA TAC
TGG AAA CCC ACT), respectively. The sense primer was
Table 7: Distinctions among the three column purification-based protocols used in this study.
Parameter Protocol 1 Protocol 2 Protocol 3
Histological sections 4 sections of 20 μm (80 μm) 1 section of 10 μm (10 μm) 2 sections of 10 μm (20 μm)
Deparaffinization 1 ml xylene 100% (3 min – 55°C) 800 μl d-limonene (5 min – room 
temperature)
1 ml d-limonene (10 min – room 
temperature)
Proteinase K incubation 3 hours – 50°C "Overnight" – 55°C 3 hours – 55°C
RNA isolation Solution provide by kit 1 Solution provide by kit 2 0.875 μl mercaptoethanol in 125 μl 
buffer provide by kit 3
DNase incubation 30 min – 37°C 45 min – 37°C 15 min – 37°C
RNA purification Solutions provided by the kit Solutions provided by the kit Solutions provided by the kitBMC Molecular Biology 2007, 8:118 http://www.biomedcentral.com/1471-2199/8/118
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cleverly designed by Liu et al. to span two exons so that it
would not anneal to or amplify genomic DNA.
Multiplex RT-PCR was carried out using Superscript™III
One-Step RT-PCR with Platinum Tag system (Invitrogen,
Carlsbad, CA) and optimized using Universal Human Ref-
erence RNA (Stratagene, La Jolla, CA) prior to testing sam-
ples. The template consisted of 0.2–2 μg of RNA from the
months old samples, depending on RNA quantity
extracted, or 100 pg of RNA from 10 year old samples.
Each reaction contained 250 pmol of sense primer and
100 pmol of each antisense primer. The first reverse tran-
scription step was performed at 50°C for 30 min. The fol-
lowing PCR steps was carried out using a ''hot-start and
touch-down'' program of 94°C for 2 minutes, followed by
1 cycle of denaturing at 94°C for 30 seconds, annealing at
66°C (one degree down per cycle until 59°C is reached)
for 30 seconds, and extension at 68°C for 45 seconds, and
then 30 cycles of 94°C for 30 seconds, 58°C for 30 sec-
onds, and 68°C for 45 seconds. A final extension was per-
formed at 68°C for 10 minutes. PCR products were
analyzed by electrophoresis on 2% agarose gels and visu-
alized using ethidium bromide staining. Fragments that
were not visible on the gel by multiplex RT-PCR were reas-
sessed by PCR with single sets of primers using the first
RT-PCR product as template.
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